A Study to Assess the Safety and Efficacy of ZPL389 With TCS/TCI in Atopic Dermatitis Patients
Clinical trial NCT03948334 · TERMINATED
Trial details
- NCT number
- NCT03948334
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-04
- Primary completion
- 2020-07-23
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.